6wHOGjifppf2_doGAdA3Vcgk9tYV6Xo_LSlbsC0p
Leadership

Sanwa BioTech has a diverse and educated management team.

20160614ImageLab3642.JPG

William is the founder of Sanwa BioTech. He has extensive knowledge in electronics, optics, precision mechanics and advanced manufacturing technologies. William is a renowned technologist and inventor, having obtained numerous design and invention awards covering telecommunications, opto-mechatronics and biotechology as well as 80 patents.

William Yim
MA

Executive Chairman & Founder,

Chief Technical Officer

Kelvin Chiu
_DSC00366_edited3.jpg

Kelvin is the co-founder of Sanwa BioTech. He was involved in multiple M&A projects and global integrations including the US$700 million acquisition of Next-Gen sequencer company, Ion Torrent. Kelvin has extensive experience in advanced biotechnology and operational strategy, and he holds a M. Phil degree in molecular biology from the University of Hong Kong and MBA from Anderson School of Business UCLA.

MBA, MPhil

Chief Executive Officer

Isabelle Dutry
Isabelle.jpg

Dr. Dutry has over 15 years of international infectious disease research experience and worked in Institute Pasteur during the SARS and avian influenza outbreak.

PhD

Chief Scientific Officer

Peter Ying
Peter.jpg

Peter has over 10 years of financial management, internal controls, risk management and financial reporting experience. He is a Member of the Hong Kong Institute of Certified Public Accountants.

CPA, LLM

Chief Financial Officer

Joey Ying
43t5y647u4-01.jpg

Joey is an environment engineering expert with over 40 years of experience. Joey is a HK delegate of Tianjin Municipal Committee in the Chinese People’s Political Consultation Conference.

MSc

Vice Chairman

Wong Ming Yam
43t5y647u4-02.jpg

MY is the former senior vice president of Royal Philips Electronic, and former Deputy Chairman of HKPC, former Chairman of HKASTRI, former director HKSTP.MY is passionate about innovation and technology development.

SBS, BBS, JP

Non Executive Director

Sam Ng
43t5y647u4-03.jpg

Sam is a successful brand builder and businessman. He is the founder and President of Max Choice, an international well-known Hong Kong brand, and he strives to incubate Hong Kong talents and technologies.

Director

WhatsApp Image 2021-04-20 at 5.54.44 PM.
Siu Mei Lee

Siu Mei has been working for 25 years in corporate governance and policy, financial and logistics management, and human resources.

General Manager

Senior Scientist

Mike Au

Mike has more than a decade of participatory experience in basic and clinical microbiology research. His Ph.D. thesis was completed at University of Hong Kong. Mike is author of over 20 peer-reviewed publications and was PI/Co-I of over 5 local research grants focused on the molecular mechanisms underlying protein functions in bacteriophages and mycobacteria.

PhD
Lok Choi

Lok was a Product & Process Scientist in a bioprocess plant in New Zealand. He developed manufacturing processes for various FDA and CE-IVD registered IVD controls for major players in the global IVD market. Prior to that, he worked in Antibody & Immunoassay Services - the commercial sector of the State Key Laboratory for Pharmaceutical Biotechnology based in the University of Hong Kong.

MPhil

Senior Scientist

Witson Chan

Witson has comprehensive knowledge in electronic hardware and software design, extensive experience in the field of electronic appliance R&D and manufacturing. He is also a certified six sigma black belt professional. He is focusing on platform R&D projects and setup automatic production lines for BioChip manufacturing expansion.

MSc

Engineering Manager

Senior Software Engineer

Shao Wei

Wei got her PhD from Nanyang Technological University, Singapore. Before moving to Hong Kong, she has over 10-year experience on the product software in medical device and in vitro diagnostics industry in Singapore, including Biobot Surgical, Veredus Laboratories and etc.

PhD
Advisory Committee Members 
Technical & Scientific Advisory Committee
Prof. Aaron Ho

Professor, Department of Biomedical Engineering

Chinese University of Hong Kong

Prof. Ho, was appointed as an Advisor in March 2019. Prof. Ho’s main contribution is in the R&D for the Company’s microfluidic BioChips and advising on issues relating to nanomaterials for photonic and sensor applications, surface plasmon resonance biosensors, nanophotonics, optical instrumentation for lab-on-chip and lab-on-a-disc devices.

Dr. Jörg Nestler 

Founder & managing director

BiFlow Systems GmbH

Dr. Nestler, was appointed as an Advisor in April 2019. Dr. Nestler’s main contribution is in the R&D for the Company’s microfluidic BioChips and advising on issues relating to microfluidic integration technologies and lab‐on‐chip applications.

Prof. C. K. Michael Tse

Associate Head and Chair Professor, Department of Industrial and Systems Engineering

Hong Kong Polytechnic University

Prof. Tse, was appointed as an Advisor in September 2021. Prof. Tse’s main contribution is in the R&D for the Company’s ALiA platform and advising on issues relating to complex network applications, internet of things and big data technologies.

Ir. Prof. K.L. Yung, BBS

Sir Sze-yuen Chung Professor in Precision Engineering; Chair Professor of Precision Engineering and Associate Head

Hong Kong Polytechnic University

Prof. Yung’s main contribution is in the R&D for the Company’s ALiA and microfluidic BioChips and advising on issues relating to precision engineering, mechatronics, automatic control system, and computer integrated manufacturing system.

Prof. CHEAH, Kok Wai

Head/Professor, Department of Physics

Hong Kong Baptist UniversityProf. Cheah, was appointed as an Advisor in September 2021. Prof. Cheah‘s main contribution is in the R&D for the Company’s microfluidic BioChip test kits and advising on issues relating to coating technologies, nano advanced organic material technologies, etc.

Prof. Ka Ming NG

Professor Emeritus, Department of Chemical and Biological Engineering

Hong Kong University of Science and Technology

Prof. Ng, was appointed as an Advisor in July 2021. Prof. Ng’s main contribution is in the R&D for the Company’s ALiA test kits and advising on issues relating to advanced materials, product and process systems engineering, especially process design and development, and biotechnology and nanotechnology-based products.

Strategic & Business Development Committee
Dr. Lewis Chan

Managing Partner

Maunakai Capital Partners (Hong Kong) Ltd.

Dr. Chan, was appointed as an Advisor in December 2020. Dr. Chan’s main contribution is in reviewing the development and implementation of the Group’s growth strategies and advising on issues relating to growth strategies, business plan delivery, the efficiency of the Group interaction with investors and shareholders of the Group, etc.

Mr. Tony Li

Former director of product marketing

Apple Inc.

Mr. Li, was appointed as an Advisor in December 2020. Mr. Li’s main contribution is in reviewing the development and implementation of the Group’s growth strategies and advising on issues relating to the execution of brand, public affairs and marketing strategies for the Group.

Medical Advisory Committee
Dr. YU Cheuk Man

Director, Heart Centre

Hong Kong Baptist Hospital

Prof. Yu’s main contribution is in the R&D for the Company’s ALiA cardiac markers panel and advising on issues relating to cardiac diseases diagnostics.

Dr. Charles Chan

Director of Business Development

Virtus Medical Group

Dr. Chan’s main contribution is in the R&D for the Company’s ALiA clinical-use panels and advising on issues relating to identifying the diagnostics needs of the community and advises on IVD applications that may be required to meet those needs and expand networks within the medical, wellness & lifestyle, insurance and financial industries in Hong Kong, Macau, and China.